Starling Oncology, Inc. (TOI) research
Starling Oncology, Inc.- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Last price
- $5.13
- As of
Starling Oncology, Inc. (TOI): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-02.
As of . Source: SEC EDGAR filings for TOI. Method and limitations.
Share the TOI intelligence card
See TOI live in the terminal
Track TOI's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live TOI terminal, freeActive signals for TOI
- highCONSENSUS_BUY
3 tracked funds increased TOI this 2026Q2, institutional consensus
- highCONSENSUS_BUY
3 tracked funds increased TOI this 2026Q2, institutional consensus
- highINSTITUTIONAL_SURGE
RENAISSANCE TECHNOLOGIES LLC added +51% to TOI (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +3236% to TOI (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +2770% to TOI (2026Q2)
FREE, NO ACCOUNT
Every signal on TOI, as it fires
You are seeing 5 of 26 signals recorded on TOI since 2026-05-26.
The five above landed across 2 days. The other 21 were recorded on 3 other days. 17 of the 26 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in TOI (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLCCUSIP 68236X100 · 2026Q2 | $7.4M | 0.01% | , |
| CITADEL ADVISORS LLCCUSIP 68236X100 · 2026Q2 | $4.9M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 68236X100 · 2026Q2 | $3.6M | 0.00% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 68236X100 · 2026Q2 | $526K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, TOI
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
TOI against its peers
TOI's operating margin of -7.2% ranks in the 26th percentile of 16 Medical Care Facilities sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-06-30.
| Metric | TOI | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 503M USD | 1.4B USD | 34 | 18 |
| Gross margin | n/a | 23.0% | n/a | 5 |
| Operating margin | -7.2% | 2.1% | 26 | 16 |
| Net margin | -12.1% | 1.4% | 13 | 18 |
| Return on equity | n/a | 5.9% | n/a | 16 |
| P / E | n/a | 24.2x | n/a | 10 |
Peers (18): SRTA, MCTA, CYH, NUTX, ARDT, INNV, AGL, AIRS, SGRY, ASTH, SNDA, ADUS, JYNT, GRDN, NHC, CON, LFST, DCGO. Left out: GMRS (no annual filing), AUNA (no annual filing), LTGHY (no annual filing), HWAIF (no annual filing), WW (no annual filing), PARK (no annual filing), BUHPY (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (TOI: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more TOI signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to TOIand get the insider, 13F, options, and confluence read in one view.